Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the 39th Annual Deutsche Bank Healthcare Conference in Boston, MA on Wednesday, May 7, 2014 at 8:40 a.m. Eastern Time. Chris Garabedian, Sarepta's president and chief executive officer, will be the presenter for a fireside chat format.
Help employers find you! Check out all the jobs and post your resume.
